EVONIK INDUSTRIES AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.38 EUR | +1.15% |
|
+1.32% | +3.48% |
| Jul. 01 | New semester, new state of mind |  |
| Jul. 01 | EVONIK : Goldman Sachs reaffirms its Neutral rating | ZD |
| Sales 2024 * | 15.42B 16.67B | Sales 2025 * | 15.82B 17.11B | Capitalization | 9.05B 9.79B |
|---|---|---|---|---|---|
| Net income 2024 * | 502M 543M | Net income 2025 * | 645M 698M | EV / Sales 2024 * | 0.81 x |
| Net Debt 2024 * | 3.41B 3.69B | Net Debt 2025 * | 3.14B 3.4B | EV / Sales 2025 * | 0.77 x |
| P/E ratio 2024 * |
18.4
x | P/E ratio 2025 * |
14.2
x | Employees | - |
| Yield 2024 * |
6.04% | Yield 2025 * |
6.1% | Free-Float | 53.48% |
More Fundamentals
* Assessed data
More news
Latest transcript on Evonik Industries AG
More press releases
More news
| 1 week | +0.94% | ||
| Current month | +2.05% | ||
| 1 month | -1.82% | ||
| 3 months | +3.14% | ||
| 6 months | +5.87% | ||
| Current year | +4.67% |
1 week
18.68
19.51
1 month
18.2019.51
3 years
15.8330.06
5 years
15.1131.00
10 years
15.1137.64
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 12-12-31 | |
Maike Schuh
DFI | Director of Finance/CFO | 50 | - |
Tim Lange
IRC | Investor Relations Contact | - | 11-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Aldo Belloni
BRD | Director/Board Member | 74 | 17-05-24 |
Werner Fuhrmann
BRD | Director/Board Member | 71 | 21-06-01 |
Bernd Tönjes
CHM | Chairman | 68 | 18-05-22 |
| Date | Price | Change |
|---|---|---|
| 24-07-04 | 19.38 | +1.15% |
| 24-07-03 | 19.16 | +1.89% |
| 24-07-02 | 18.8 | -0.58% |
| 24-07-01 | 18.92 | -0.39% |
| 24-06-28 | 18.99 | -1.09% |
Delayed Quote Börse Stuttgart, July 04, 2024 at 03:55 pm EDT
More quotes
Evonik Industries AG is a Germany-based specialty chemicals company. The Company engages in the development, construction, distribution and trade of scientific equipment, chemicals and accessories for use in the fields of life sciences and biotechnology.
Sector
Specialty Chemicals
Calendar
2024-08-01
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
19.42
EUR
Average target price
22.02
EUR
Spread / Average Target
+13.41%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.91% | 67.35B | |
| -4.82% | 45.56B | |
| +23.97% | 44.14B | |
| +37.24% | 28.89B | |
| +10.06% | 19.28B | |
| +14.01% | 17.32B | |
| -25.35% | 14.85B | |
| -13.27% | 14.72B | |
| -29.84% | 12.07B |
- Stock Market
- Equities
- EVK Stock
- EVK Stock
